MGP Ingredients (MGPI) Earnings Analysis
MGP Ingredients (MGPI) next reports earnings on 2026-07-29, consensus EPS 0.49 USD. Last quarter (2026-02-25) it beat with EPS 0.63 USD vs 0.49 USD est (+28.6%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E -1.62.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MGPI next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 0.49 USD |
| Revenue estimate | 0.13B |
MGPI earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | 0.63 USD | 0.49 USD | +28.6% | Beat |
| 2025-10-29 | 0.85 USD | 0.62 USD | +37.1% | Beat |
| 2025-07-31 | 0.97 USD | 0.64 USD | +51.6% | Beat |
| 2025-05-01 | 0.36 USD | 0.31 USD | +16.1% | Beat |
| 2025-02-26 | 1.57 USD | 1.49 USD | +5.4% | Beat |
| 2024-10-31 | 1.29 USD | 1.25 USD | +3.2% | Beat |
| 2024-08-01 | 1.71 USD | 1.54 USD | +11% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
MGPI valuation and analyst view
| Trailing P/E | -1.62 |
|---|---|
| Trailing EPS | -11.20127 USD |
| Price / book | 0.67 |
| Dividend yield | 2.65% |
| Market cap | 0.39B |
| Analyst consensus | Buy (10 buy / 4 hold / 0 sell) |
| Avg price target | 21 USD |
Related research pages
Frequently asked questions
When is MGP Ingredients (MGPI)'s next earnings date?
MGP Ingredients is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.49 USD and revenue estimate of 0.13B.
Did MGPI beat earnings last quarter?
In its 2026-02-25 report, MGPI posted EPS of 0.63 USD versus a 0.49 USD estimate — a beat of 28.6%.
What is MGPI's earnings track record?
Over the last 7 reported quarters with consensus data, MGPI beat estimates 7 times (100%).
What is MGPI's current P/E ratio and EPS?
MGPI trades at a trailing P/E of -1.62 on trailing EPS of -11.20127449801049 USD.
What do analysts rate MGPI?
Analyst consensus is "Buy" across 14 ratings (0 strong buy, 10 buy, 4 hold, 0 sell, 0 strong sell). Average 12-month price target: 21 USD.